Reposted by Nia Hammond
1/For over a decade, we’ve been studying tumor metabolism in patients with non-small cell lung cancer
This long-term commitment allowed us to connect tumor metabolic features to patient outcomes
We found that 13C glucose contribution to the TCA cycle predicts overall survival in NSCLC